Baxter International (BAX) - צמיחת רווח נקי למניה אחת לשנה הנוכחית

Baxter International is reorganizing its structure to improve margins by spinning off its nephrology segment and diversifying its component supply chains. The annual percentage growth in net income per share demonstrates EPS dynamics, where the -4.90 figure serves as the target level. The issuer's revenues are based on the mass production of dialysis systems, infusion solutions, and anesthesia agents.

Baxter International is optimizing its asset structure by spinning off its kidney care business to focus on high-margin hospital IT systems and instrumentation. The YoY EPS growth trend measures the annual rate of increase in earnings per share, allowing investors to lock in profits or exit the asset if the metric turns negative, which signals a systemic decline in revenue and contracting liquidity.